As filed with the Securities and Exchange Commission on August 16, 2004

                                                  Registration No.  333-114483
------------------------------------------------------------------------------

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                 ------------

                                 Amendment No. 2
                                       to
                                    Form S-3

             REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

                                  ------------

                        TOR MINERALS INTERNATIONAL, INC.
             (Exact name of registrant as specified in its charter)

    Delaware                           722 Burleson                74-2081929
(State or jurisdiction of        Corpus Christi, Texas 78402   (I.R.S. Employer
incorporation or organization)        (361) 883-5591         Identification No.)

    (Address, including zip code, and telephone number, including area code,
                  of registrant's principal executive offices)

     Richard L. Bowers                                   With a copy to:
   Chief Executive Officer                               L. Steven Leshin
TOR Minerals International, Inc.                        Jenkens & Gilchrist,
       722 Burleson                                  a Professional Corporation
  Corpus Christi, Texas 78402                      1445 Ross Avenue, Suite 3200
      (361) 883-5591                                     Dallas, Texas 75202
(Name, address and telephone number of agent               (214) 855-4500
        for service)
                                  ------------

APPROXIMATE  DATE OF PROPOSED  SALE TO THE  PUBLIC:  From time to time after the
effective date of this Registration Statement.

     If the only  securities  being  registered  on this form are being  offered
pursuant to dividend or interest  reinvestment plans, please check the following
box. [ ]

     If any of the securities being registered on this form are to be offered on
a delayed or continuous  basis  pursuant to Rule 415 under the Securities Act of
1933, other than securities offered only in connection with dividend or interest
reinvestment plans, check the following box. [X]

     If this form is filed to  register  additional  securities  for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list  the  Securities  Act  registration  statement  number  of the  earlier
effective registration statement for the same offering. [ ]

         If this Form is a post-effective amendment filed pursuant to Rule
462(c) under the Securities Act, check the following box and list the Securities
Act registration statement number of the earlier effective registration
statement for the same offering. [ ]

     If delivery of the  Prospectus is expected to be made pursuant to Rule 434,
please check the following box. [ ]

     THE REGISTRANT  HEREBY AMENDS THIS  REGISTRATION  STATEMENT ON SUCH DATE OR
DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL
FILE A  FURTHER  AMENDMENT  THAT  SPECIFICALLY  STATES  THAT  THIS  REGISTRATION
STATEMENT SHALL  THEREAFTER  BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(a) OF
THE  SECURITIES  ACT OF 1933, AS AMENDED,  OR UNTIL THE  REGISTRATION  STATEMENT
SHALL BECOME  EFFECTIVE ON SUCH DATE AS THE COMMISSION,  ACTING PURSUANT TO SAID
SECTION 8(a), MAY DETERMINE.

-------------------------------------------------------------------------------

PROSPECTUS

                        TOR MINERALS INTERNATIONAL, INC.
                        3,376,316 SHARES OF COMMON STOCK


     This is a public offering of up to 3,376,316  shares of our common stock by
certain of our  stockholders.  The shares  offered  by this  prospectus  include
3,376,316  presently  outstanding shares of our common stock. We are not selling
any shares of our common stock under this prospectus and we will not receive any
of  the  proceeds   from  the  shares  of  common  stock  sold  by  the  selling
stockholders.

     The prices at which the selling stockholders may sell the shares registered
under this prospectus will be determined by the prevailing  market price for the
shares or in negotiated transactions.

     Our common stock is listed on The Nasdaq  Stock  Market's  SmallCap  Market
under the symbol "TORM." On August 13, 2004, the last reported sale price for
our common stock was $3.98 per share.

     The selling  stockholders  may sell the shares of common stock described in
this prospectus in a number of different ways and at varying prices.  We provide
more information about how the selling stockholders may sell their shares in the
section entitled "Plan of Distribution; Selling Stockholders" on page 7.

     INVESTING IN OUR COMMON STOCK INVOLVES  RISKS.  FOR A DISCUSSION OF CERTAIN
FACTORS THAT SHOULD BE  CONSIDERED  IN  EVALUATING  AN  INVESTMENT IN THE COMMON
STOCK OFFERED HEREBY, SEE "RISK FACTORS" BEGINNING ON PAGE 4 OF THIS PROSPECTUS.

     Neither the  Securities and Exchange  Commission  nor any state  securities
commission has approved or disapproved of these securities or determined if this
prospectus  is truthful or  complete.  Any  representation  to the contrary is a
criminal offense.

     We are not using this  prospectus  to offer to sell these  securities or to
solicit  offers to buy these  securities in any place where the offer or sale is
not permitted.

              THE DATE OF THIS PROSPECTUS IS ______________, 2004.


                                       2

                                TABLE OF CONTENTS



PROSPECTUS SUMMARY...........................................................1
RISK FACTORS.................................................................3
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS............................6
USE OF PROCEEDS..............................................................6
PLAN OF DISTRIBUTION; SELLING STOCKHOLDERS...................................7
LEGAL MATTERS...............................................................10
INDEMNIFICATION OF DIRECTORS................................................10
EXPERTS.....................................................................11
WHERE YOU CAN FIND MORE INFORMATION.........................................11
INCORPORATION BY REFERENCE..................................................11

     You should rely only on the  information  contained in this  document or to
which we have  referred you. We have not  authorized  anyone to provide you with
information that is different.  This document may only be used where it is legal
to sell these securities.







                               PROSPECTUS SUMMARY

     This summary highlights the most significant  aspects of this offering that
should be  considered by  prospective  investors but does not contain all of the
information  that you should  consider  before  making an investment in TOR. You
should  read the  entire  prospectus  carefully,  including  the "Risk  Factors"
section and the documents listed under "Where You Can Find More Information."

About TOR Minerals International, Inc.

     TOR Minerals International, Inc. is a specialty chemical company engaged in
the  business  of  manufacturing  and  marketing  mineral  products  for  use as
pigments,  pigment  extenders and flame  retardants  used in the  manufacture of
paints, industrial coatings, plastics and solid surface applications.

     We are  headquartered in Corpus Christi,  Texas,  USA. This location houses
senior  management,  customer  service,  logistics  and  corporate  research and
development  laboratories.  Our financial and accounting  functions also operate
from this location.  Our principal  offices in Corpus Christi are located at 722
Burleson  Street,  Corpus Christi,  Texas 78402,  and our telephone number (361)
883-5591.  Our  website is located  at  http://www.torminerals.com.  Information
contained on our website or links contained on our website is not a part of this
prospectus.

     We maintain three  manufacturing  sites located in Corpus  Christi,  Texas;
Ipoh, Perak, Malaysia; and Hattem, The Netherlands.


                                       1

Our Products

     Our mineral products include:

     o    HITOX,  a  light  buff-colored  titanium  dioxide  pigment  made  from
          synthetic rutile,  which is our principal product.

     o    ALUPREM,(R)  which is used for  color  critical  applications  such as
          Solid  Surface/Onyx and performance driven uses such as specialty wire
          and cable insulation,  catalysts,  high-tech  polishing,  pigments and
          specialty papers.

     o    SYNTHETIC RUTILE, which the basic building block for HITOX.

     o    BARTEX,(R) which gives weight and body to products ranging from powder
          coatings  used in appliance  and office  furniture  finishes to rubber
          products  such as carpet and curtain  backings and plastics  including
          billiard balls and poker chips.

     o    HALTEX,(R)   which  is  suitable   for  a  broad  range  of  technical
          applications including electrical wire and cable insulation, thermoset
          SMC/BMC  molding  compounds,  thermoplastic  profiles,  PVC and rubber
          products, specialty coatings as well as adhesives and sealants.

About this Offering

     Effective January 19, 2004, we sold in a privately  negotiated  transaction
200,000 shares of convertible  preferred stock in return for $1 million in cash.
The preferred  stock has a 6% dividend rate and each share of preferred stock is
convertible  into 0.84  shares  of our  common  stock.  The  preferred  stock is
redeemable  at our option  after two years.  We also sold in the same  privately
negotiated  transaction  526,316  shares of  common  stock at $4.75 per share to
existing stockholders and new institutional holders for $2.5 million in cash. In
connection with the private  placement of the 526,316 common shares,  we entered
into a Common Stock Purchase Agreement with the selling stockholders, whereby we
agreed to  prepare  and file  with the  Securities  and  Exchange  Commission  a
registration  statement with respect to the resale of the shares  purchased from
us in the private placement. Additionally, we have agreed to register the resale
of 100,000 shares of common stock acquired by certain  stockholders in a private
resale on October 21, 2003,  1,000,000  shares held by Megamin Ventures Sdn Bnd,
which  were  acquired  by  Megamin  from  us or  our  stockholders  in  multiple
transactions  in 1995,  1996 and 2000, and 1,755,000  shares of our common stock
acquired by certain  stockholders,  including  several of our directors or their
affiliates,  in April 2001.  Beginning in 1995,  Megamin purchased shares of our
common  stock  on the open  market.  In June  1996,  Megamin  purchased  from us
1,000,000  shares of our  common  stock  for  $4.00 per share in an arms  length
transaction.  At the same time, Megamin purchased 200,000 shares from individual
stockholders  of TOR also at a $4.00 purchase  price.  In March 2000, TOR issued
500,000  shares of common  stock to Megamin as part of the purchase of a private
Malaysian company from Megamin. Our shares closed at $2.00 on the effective date
of purchase.  In the April 2001  transaction,  we issued  301,000  shares of our
common  stock for $1.00 per  share,  which was above the  closing  price at that
time, and we issued $2,709,000  principal amount of convertible  debentures at a
conversion price of $1.80. All the debentures have  subsequently  been converted
into shares of our common stock. The terms of the private  placement were agreed
to with two lead investors who had no previous investment in our relationship to
us but  purchased  approximately  66% of the  amount  raised.  In total,  we are
registering  3,376,316 shares of common stock for public resale pursuant to this
prospectus.



                                       2

                                  RISK FACTORS

     You should consider  carefully the following risks before making a decision
to buy our common  stock.  If any of the following  risks  actually  occur,  our
business,  financial  condition or results of operations would likely suffer. In
such case, the trading price of our common stock could decline, and you may lose
all or part of the  money you paid to buy our  common  stock.  The risk  factors
below do not necessarily appear in order of importance.

Risks Related to our Business

     Our debt is  subject  to  subjective  acceleration  provisions  and  demand
provisions  that allow our lending  institutions  to  accelerate  payment at any
time. If our debt were accelerated under the demand  provisions,  we do not have
sufficient resources to repay that debt.

     We  have  borrowed  domestically  $2,825,000  under a line  of  credit  and
$580,833  under a term loan as of December  31, 2003 with Bank of America,  N.A.
The  terms of our  borrowings  contain  restrictions  and  covenants,  including
subjective  acceleration  provisions  based  on the  judgment  of the  bank  and
covenants  based on our  performance.  The  bank  could  determine  based on the
subjective covenants that we are in default and could demand payment.

     Our  subsidiaries  have loan  agreements  with  banks in  Malaysia  and the
Netherlands that provide short-term credit facilities. At December 31, 2003, the
subsidiaries  had borrowed  $1,500,947  under these  facilities.  All borrowings
under the short term credit facilities are subject to demand  provisions,  which
could be exercised at any time.

     The banks have made no indication  that they will demand  payment of any of
our loans in the United States, Malaysia, or the Netherlands; however, there can
be no assurances  that this debt will not be called in the future.  If demand is
made by the banks, we may require  additional  debt or equity  financing to meet
our working capital and operational  requirements or, if required,  to refinance
maturing  or  demanded  indebtedness.  Should  we find  it  necessary  to  raise
additional  funds,  we may find that such  funds are  either  not  available  or
available  only on  terms  that  are  unattractive  in  terms  of  stockholders'
interest, or both.

     We have one primary source for synthetic  rutile and if that source was not
available, we could not produce our primary product, HITOX.

     TOR Minerals Malaysia, our wholly-owned  subsidiary,  is our primary source
for synthetic  rutile.  There is only one other available source for the quality
of  synthetic  rutile  required  for the  production  of HITOX.  If  supplies of
synthetic rutile from TOR Minerals Malaysia are interrupted and we are unable to
arrange for an alternative source, this could result in our inability to produce
HITOX,  which  accounts  for  approximately  48% of our sales for the year ended
December 31, 2003.

     We are  dependent  on a limited  number of customers  and could  experience
significant revenue reductions if they use alternative sources.

     We derive a significant  portion of our revenue each quarter from a limited
number of customers.  For the year ended December 31, 2003,  sales to Kerr-McGee
Chemical  Corporation  through a multi-year contract accounted for approximately
15% of our total revenues.  Our top 10 customers,  including Kerr-McGee Chemical
Corporation,  accounted  for  approximately  48% of our sales in 2003. We expect
that a limited  number of customers  will  continue to account for a substantial
portion of our revenue for the  foreseeable  future.  As a result,  if we lose a
major customer, our revenue would be adversely affected.

     The value of our inventory is in part based on management  projections that
could result in inventory write-downs if market demands or conditions erode.

     We write down our  inventory  for estimated  obsolescence  or  unmarketable
inventory  such that  inventory is carried at the lower of the cost of inventory
and the estimated  market value based upon  assumptions  about future demand and
market  conditions.  If  actual  future  demand or  market  conditions  are less
favorable  than those  projected by  management,  inventory  write-downs  may be
required which in turn could adversely affect our  profitability  and compliance
with our required loan covenants.


                                       3

     We review  impairment  of goodwill  annually to  determine  if the carrying
value has been  impaired.  If we were to  determine  that our  goodwill has been
impaired, it could result in a significant charge to our results from operations
and income.

     We review  goodwill at least  annually to determine if any  impairment  has
occurred or more  frequently if indicators of impairment  are noted.  Because no
indicators of impairment  were noted in 2003, we performed this annual review in
October  2003,  and have  determined  that no  impairments  existed at that time
related to the $1,283,000 carrying value of goodwill.  There can be no assurance
that  future  goodwill  impairment  tests  will not  result  in a charge  to net
earnings (loss).

     Foreign  currency   fluctuations   could  adversely  impact  our  financial
condition.

     Because we own assets located outside the United States and derive revenues
from  our  international  operations,  we may  incur  currency  transaction  and
translation losses due to changes in the values of foreign currencies and in the
value of the US dollar.  In 2003, due to the effect of the weakening  dollar, as
compared to 2002, we experienced a $358,000  reduction in net income.  We cannot
predict  the  effect of  changes  in  exchange  rate  fluctuations  upon  future
operating results.

     We review our assets for impairment  whenever  events or changes  dictate a
review which may require us to take a charge to net earnings (loss).

     We have adopted  Statements  of  Financial  Accounting  Standards  No. 144,
Accounting for the Impairment of or Disposal of Long Lived Assets. We review for
indicators  that these assets are  impaired in  accordance  with this  standard,
whenever events or changes in circumstances indicate that the carrying amount of
the long-lived asset or group of assets might not be recoverable. No impairments
have been recorded  during the years ended December 31, 2002 or 2003.  There can
be no assurance that future long-lived asset impairment tests will not result in
a charge to net earnings (loss).

     We borrow  funds from time to time from  members of our board of  directors
for working capital purposes.

     In the  past,  we have had to borrow  funds  from  members  of our board of
directors  for working  capital  purposes.  At December 31,  2003,  we had loans
amounting to $1,230,735  outstanding  to various  directors.  The purpose of the
loans was for working capital.  As of March 31, 2004, the remaining  outstanding
balance was reduced to  $500,000.  It is  possible we could  require  additional
working capital loans in the future, but it is possible that such loans from our
board  members would not be available as they have made no commitment to provide
additional loans.

     Our competitors are established companies that have greater experience than
us in a number of crucial areas, including manufacturing and distribution.

     There is intense competition with respect to each of our products. In order
to maintain sales volume, we must consistently  deliver high quality products on
schedule at competitive  prices.  Our competitors range from large  corporations
with full lines of production  capabilities and products, such as E.I. DuPont de
Nemours & Co., Inc., Millenium Chemical Inc.,  Kerr-McGee Chemical  Corporation,
Kronos Inc.  and J.M.  Huber,  to small local firms  specializing  in one or two
products.  The established  companies have significantly greater experience than
us in manufacturing  and distributing  our products and have  considerably  more
resources and market share,  and we may have  difficulty in competing with these
companies.

     Increases in freight costs and certain raw material prices could negatively
affect future gross margins.

     Recent  increases in freight costs and prices of certain raw materials will
negatively  affect our future  gross  margins.  The extent of that  impact  will
depend on future  product mix and whether the cost  increases  could be absorbed
through end customer price  increases.  It is possible that increases in freight
costs and prices of raw materials will adversely  impact our future results from
operations where these increased costs cannot be offset by correspondingly  high
sales prices.

Risks Related to this Offering

     Our stock price historically has been volatile, which may make it difficult
for you to resell common stock you want at prices you find attractive.

                                       4


     The market price of our common  stock has been and will likely  continue to
be highly volatile. Any significant fluctuations in the future might result in a
material decline in the market price of our common stock. These fluctuations may
be caused by factors such as:

     o    actual or anticipated variations in quarterly operating results;

     o    announcements of technological innovations;

     o    new sales formats of new products or services;

     o    announcements  by us or our  competitors of significant  acquisitions,
          strategic partnerships or joint ventures;

     o    capital commitments;

     o    additions or departures of key personnel; and

     o    sales of common stock.

     The sale of a significant  number of shares could have a depressive  effect
on the market price of our common stock.

     It is possible  that a  significant  number of shares  could be sold at the
same time under this prospectus, and such sales, or the possibility thereof, may
have a depressive effect on the market price of our common stock.


                                       5

                SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

     This  prospectus  contains  statements  that  constitute   "forward-looking
statements" within the meaning of the Private  Securities  Litigation Reform Act
of 1995.  These  statements can be identified by the use of  predictive,  future
tense  or  forward-looking  terminology,   such  as  "anticipates,"  "believes,"
"estimates,"  "expects,"  "intends," "may," "will" and words of similar meaning.
These statements include statements  regarding,  among other things, our product
and service development, projected capital expenditures,  liquidity and capital,
development of additional  revenue sources,  expansion into new market segments,
technological advancement, ability to retain our customers and market acceptance
of our products. These statements are based on management's current expectations
and are subject to a number of  uncertainties  and risks that could cause actual
results to differ  significantly  from those  described  in the  forward-looking
statements,  including changes in demand for our products,  changes or increases
in   competition,   economic   conditions,   fluctuations   in  exchange  rates,
fluctuations  in market price for TiO2  pigments,  interest  rate  fluctuations,
changes in the capital markets,  changes in freight and transportation  charges,
changes in the cost to us if natural  gas  necessary  to conduct  our  business,
changes in tax and other laws and governmental rules and regulations  applicable
to our business.  Readers of this  prospectus  are  cautioned to consider  these
risks and uncertainties and to not place undue reliance on these forward-looking
statements.

                                 USE OF PROCEEDS

     We will not  receive  any  proceeds  from the sale of  common  stock by the
selling stockholders.




                                       6


                   PLAN OF DISTRIBUTION; SELLING STOCKHOLDERS

     This prospectus  relates to up to 3,376,316 shares of our common stock that
may be  offered  and sold from  time to time by the  selling  stockholders.  The
shares offered by this prospectus include 3,376,316 presently outstanding shares
of our common stock.  The following  table sets forth the name and  relationship
with us of the selling stockholders and (i) the number of shares of common stock
beneficially  owned  by the  selling  stockholders  as of May 27,  2004  (unless
otherwise  indicated),  (ii) the maximum  number of shares of common stock which
may be offered by this  prospectus  for the account of the selling  stockholders
and (iii) the amount and  percentage  of common stock that would be owned by the
selling stockholders after completion of the offering,  assuming the sale of all
of the common stock which may be offered by this prospectus. The information set
forth below has been  provided by the  selling  stockholders,  as of the date of
this  prospectus,  regarding  the  beneficial  ownership of shares of our common
stock by the selling stockholders.


                                                                                                   Common Stock
                                                                           Number of           Beneficially Owned
                                              Number of Shares           Shares of Common        After Offering (2)
                                              Of Common Stock         Stock Registered and     --------------------
           Selling Stockholder              Beneficially Owned (1)           Offered            Number      Percent
           -------------------              ----------------------    --------------------      -------     -------
                                                                                                   

Anthony Replacement Account (3)                     7,500                      7,500                0           *
Bedrock Capital (4)                                40,000                     40,000                0           *
W.  Craig Epperson (5)                             59,880                     15,000             44,880         *
Donald V.  Moline                                   3,000                      3,000                0           *
Frost National Bank FBO
Renaissance US Growth Investment
Trust PLC (6)                                     290,000                    290,000                0           *
Frost Prioleau                                      5,400                      5,400                0           *
George Karutz                                      40,400                     30,000             10,400         *
Gustave L.  Levinson Marital Trust (7)             10,000                     10,000                0           *
Harold L.  Gilbert                                  5,000                      5,000                0           *
IRA FBO George S.  Taylor                          25,000                     25,000                0           *
IRA FBO James R.  Foutch                           10,000                     10,000                0           *
John Bertsch                                       10,000                     10,000                0           *
John S.  Lemak                                     25,000                     25,000                0           *
John W.  Anthony                                    5,000                      5,000                0           *
Joseph D.  Chamberlain                             10,000                     10,000                0           *
Joseph Martha                                       2,000                      2,000                0           *
Kuekenhof Equity Fund, L.P. (8)                    45,000                     45,000                0           *
LKCM Investment Partnership (9)                   105,000                    105,000                0           *
Mark E.  Anthony                                    8,916                      3,416              5,500         *
Megamin Ventures Sdn Bhd(10)                    1,106,355                  1,000,000            106,355       1.38%
MTB Capital, LLC (11)                              15,000                     15,000                0           *
Paulson Ranch, Ltd.(12)                         1,201,774                    300,000            901,774      11.71%
Robert F.  Taglich                                  5,000                      5,000                0           *
Robert W.  Main                                     5,000                      5,000                0           *
Sandor Capital Master Fund, LP (13)                45,000                     45,000                0           *
Special Trust for Nina B. Sando (14)                5,000                      5,000                0           *
T2, Ltd. (15)                                      30,000                     30,000                0           *
The D and CH Trust (16)                           617,500                    600,000            17,500          *
The Douglas MacDonald Hartman Family
Irrevocable Trust(17)                             617,500                    600,000            17,500          *
Thomas J.  Bean                                     5,000                      5,000                0           *
Victory Equity Portfolio, LP (18)                  15,000                     15,000                0           *
WS Opportunity Fund (QP), LP (19)                36,600(8)                    36,600                0           *
WS Opportunity Fund International, Ltd. (19)     39,200(8)                    39,200                0           *
WS Opportunity Fund, LP (19)                     29,200(8)                    29,200                0           *


*Indicates less than 1%.

                                       7


     (1)  Unless otherwise  indicated,  to our knowledge,  the entities named in
          the table have the sole voting and sole investment  power with respect
          to all  shares of our  common  stock  beneficially  owned,  subject to
          community property laws where applicable.
     (2)  Because  the selling  stockholders  may sell all or a portion of their
          shares of common stock  pursuant to this  prospectus at any time,  and
          from time to time,  no estimate can be made of the number of shares of
          common stock that the selling  stockholders may retain upon completion
          of the  offering by the selling  stockholders.  Therefore,  this table
          assumes that all shares of our common stock offered by this prospectus
          by the selling  stockholders  are actually sold. Such  presentation is
          based on 7,701,753 shares of our common stock  outstanding as of March
          10, 2004.
     (3)  James  Anthony has voting or  investment  control over the  securities
          listed.
     (4)  W. Craig  Epperson has been a member of the Board of  Directors  since
          1999. Includes currently  exercisable options to acquire 20,000 shares
          of our common stock.
     (5)  James C.  Smith or James F.  Gallan,  Jr.  have  voting or  investment
          control over the securities listed.
     (6)  Russell Cleveland has voting or investment control over the securities
          listed.
     (7)  Gustave  L.  Levinson  has  voting  or  investment  control  over  the
          securities listed.
     (8)  Michael  James has voting or  investment  control over the  securities
          listed.
     (9)  J. Luther King, Jr., general partner, has voting or investment control
          over the securities listed.
     (10) Dato K. K. Lim, who is the controlling shareholder of Megamin Ventures
          Sdn Bhd,  has been  represented  on our Board of Directors by his son,
          Lim Si Boon, and his  son-in-law,  Dr. Tan Chin Yong,  since the years
          2000 and 2001, respectively.
     (11) Tristan Barr is the managing  member of MTB Capital LLC and has voting
          or investment control over the securities listed.
     (12) Bernard  A.  Paulson  is  Chairman  of the  Board and has been a board
          member since 1992.  Paulson Ranch Management,  L.L.C., a Texas limited
          liability  company,  is the general  partner of Paulson Ranch Ltd. The
          members of Paulson Ranch Management, L.L.C. are Bernard A. Paulson and
          his wife. The principal business is investment in securities.  Paulson
          Ranch, Ltd. disclaims  beneficial  ownership of the 48,100 shares held
          by Mr. Paulson and his wife and disclaims  beneficial ownership of the
          14,600  shares held by his wife.  This number  includes (a)  1,109,074
          shares held for the account of Paulson  Ranch,  Ltd. (b) 62,700 shares
          held by Mr. Paulson's account and (c) options to acquire 30,000 shares
          of our common stock  exercisable  at or within 60 days of May 17, 2004
          held for Mr. Paulson's account.
     (13) John S. Lemak,  general partner, has voting or investment control over
          the securities listed.
     (14) Nina B. Sando has voting or  investment  control  over the  securities
          listed.
     (15) James C. Smith,  manager,  has voting or  investment  control over the
          securities listed.
     (16) David A.  Hartman  has been a member of the Board of  Directors  since
          2001. Mr. Hartman is trustee of the D and CH Trust.  Includes  options
          to acquire 17,500 shares of our common stock  exercisable at or within
          60 days of May 17, 2004 held for Mr. Hartman's account.
     (17) Douglas M. Hartman has been a member of the Board of  Directors  since
          2001. Mr. Hartman is trustee of The Douglas  MacDonald  Hartman Family
          Irrevocable  Trust.  Includes  options to acquire 17,500 shares of our
          common stock exercisable at or within 60 days of May 17, 2004 held for
          Mr. Hartman's account.
     (18) Mark  Anthony and William  Baldwin have voting or  investment  control
          over the securities listed.
     (19) Total amount of shares held collectively  between WS Opportunity Fund,
          LP,  WS  Opportunity   Fund  (QP),   LP,  and  WS   Opportunity   Fund
          International,  Ltd. is 105,000. Patrick P. Walker, Reid S. Walker and
          G. Stacy Smith have voting or investment  control over the  securities
          listed.

     Effective January 19, 2004, we sold 526,316 shares of common stock at $4.75
per  share to  existing  stockholders  and new  institutional  holders  for $2.5
million in cash. In connection with the private placement of the 526,316 shares,
we entered into a Common Stock Purchase Agreement with the selling stockholders,
whereby  we  agreed  to  prepare  and file  with  the  Securities  and  Exchange
Commission a  registration  statement  with respect to the offer and sale of the
shares from the private placement.  Additionally, we have agreed to register the
resale of 100,000 shares of common stock acquired by certain  stockholders  in a
private resale on October 21, 2003 and 1,000,000  shares of common stock held by
Megamin Ventures Sdn Bhd acquired from us in multiple transactions in 1996, 1996

                                       8


and 2000. Beginning in 1995, Megamin purchased shares of our common stock on the
open market.  In June 1996,  Megamin  purchased from us 1,000,000  shares of our
common  stock for $4.00 per  share in an arms  length  transaction.  At the same
time, Megamin purchased 200,000 shares from individual  stockholders of TOR also
at a $4.00  purchase  price.  In March 2000, TOR issued 500,000 shares of common
stock to Megamin as part of the  purchase of a private  Malaysian  company  from
Megamin.  Our shares closed at $2.00 on the effective date of purchase.  We have
additionally  agreed to register  the resale of  1,755,000  shares of our common
stock that was  privately  placed by us with  investors  in April 2001.  In that
transaction,  we issued  301,000  shares  of our  common  stock  and  $2,709,000
principal   amount  of  convertible   debentures  for  total   consideration  of
$3,010,000.  The common  stock was sold for $1.00 per  share,  which was a price
above our  closing  price at that  time,  and the  convertible  debentures  were
convertible at $1.80 per share of common stock. All convertible  debentures have
been converted.  The terms of the private placement were agreed to with two lead
investors who had no previous  investment in or relationship to us but purchased
approximately  66%  of  the  amount  raised.  Of  the  1,755,000  shares  we are
registering  for  resale,  1,515,000  shares  of  common  stock  are held by our
directors or their affiliates.

     The selling  stockholders  will act independently of us in making decisions
with  respect  to the  timing,  manner and size of each  sale.  As used  herein,
"selling  stockholders"  includes  pledgees,   donees,   transferees  and  other
successors in interest to the selling  stockholders selling shares received from
the  selling  stockholders  after  the  date of  this  prospectus.  The  selling
stockholders may effect such  transactions by selling the shares of common stock
to or through  broker-dealers,  and such broker-dealers may receive compensation
in  the  form  of  discounts,   concessions  or  commissions  from  the  selling
stockholders  and/or the purchasers of the shares of common stock for which such
broker-dealers may act as agent or to whom they may sell as principal,  or both.
We are not aware as of the date of this prospectus of any agreements between the
selling  stockholders  and any  broker-dealers  with  respect to the sale of the
shares of common stock offered by this prospectus.

     In  connection  with  distributions  of  the  shares  of  common  stock  or
otherwise,  the selling  stockholders may enter into hedging  transactions  with
broker-dealers. In connection with such transactions,  broker-dealers may engage
in short sales of the shares of common stock registered under this prospectus in
the course of hedging the positions they assume with selling  stockholders.  The
selling  stockholders may also sell shares of our common stock short and deliver
the shares of common  stock to close out such short  positions.  WS  Opportunity
Fund,   L.P.,  WS  Opportunity   Fund  (QP),   L.P.  and  WS  Opportunity   Fund
International,  Ltd.  have  informed  us that as of July  19,  2004,  they  have
established a short position in our shares.  The selling  stockholders  may also
enter into option or other  transactions  with  broker-dealers  that require the
delivery to the  broker-dealer  of the shares of common stock  registered  under
this prospectus, which the broker-dealer may resell pursuant to this prospectus.
The selling  stockholders  may also pledge the shares of common stock registered
hereunder  to a broker or dealer  and upon a  default,  the broker or dealer may
affect sales of the pledged shares of common stock pursuant to this prospectus.

     The selling  stockholders  and any broker,  dealer or other agent executing
sell  orders  on  behalf  of  the  selling  stockholders  may  be  deemed  to be
"underwriters"  within  the  meaning  of the  Securities  Act,  in  which  event
commissions  received  by any such  broker,  dealer or agent  and  profit on any
resale of the shares of principal may be deemed to be  underwriting  commissions
under the Securities Act. Such commissions received by a broker, dealer or agent
may be in excess of customary  compensation.  Five selling stockholders,  namely
John S. Lemak, Mark E. Anthony,  Robert F. Taglich,  Sandor Capital Master Fund,
L.P.  and  Victory  Equity  Portfolio,  L.P.,  have  informed  us that  they are
affiliates  of broker  dealers.  Each of these five  selling  stockholders  also
certified  to us that they  bought the common  stock in the  ordinary  course of
business,  and at the time of the purchase of the common stock to be resold, had
no  agreements or  understandings,  directly or  indirectly,  with any person to
distribute the common stock.

     The  shares  of  common  stock  may  also be sold in  privately  negotiated
transactions or pursuant to Rule 144 under the Securities Act.

     Information as to whether  underwriters  who may be selected by the selling
stockholders,  or any other broker-dealer,  are acting as principal or agent for
the selling  stockholders,  the  compensation to be received by underwriters who
may be selected by the selling  stockholders,  or any  broker-dealer,  acting as
principal  or agent for the  selling  stockholders  and the  compensation  to be
received by other  broker-dealers,  will, to the extent  required by law, be set
forth in a supplement to this prospectus.  Any dealer or broker participating in
any  distribution of the shares of our common stock may be required to deliver a
copy of this  prospectus,  including the prospectus  supplement,  if any, to any

                                       9


person who  purchases any of the shares of our common stock from or through such
dealer or broker.

     All expenses of registration  incurred in connection with the offering will
be  borne  by us.  All  selling  and  other  expenses  incurred  by the  selling
stockholders will be borne by the selling stockholders.

     The selling  stockholders  will be subject to applicable  provisions of the
Securities Exchange Act of 1934 and its rules and regulations, including without
limitation,  Rule 102 under  Regulation M, which provisions may limit the timing
of purchases  and sales of any of the common stock by the selling  stockholders.
Rule 102 under  Regulation  M  provides,  with  certain  exceptions,  that it is
unlawful for a selling  stockholder or its affiliated  purchaser to, directly or
indirectly,  bid for or  purchase  or attempt to induce any person to bid for or
purchase,  for an  account  in  which  the  selling  stockholder  or  affiliated
purchaser has a beneficial  interest in any  securities  that are the subject of
the distribution during the applicable restricted period under Regulation M. All
of the  foregoing  may affect the  marketability  of the common  stock.  We will
require the selling stockholder, and his or her broker if applicable, to provide
a letter that  acknowledges  his compliance  with  applicable  securities  laws,
including Regulation M under the Securities Exchange Act, before authorizing the
transfer of such selling stockholder's shares of common stock.

     It is possible  that a  significant  number of shares  could be sold at the
same time under this prospectus, and such sales, or the possibility thereof, may
have a depressive effect on the market price of our common stock.

                                  LEGAL MATTERS

     The validity of the common stock offered by this prospectus has been passed
upon by Jenkens & Gilchrist, a Professional Corporation, Dallas, Texas.

                          INDEMNIFICATION OF DIRECTORS

     Section 145 of the Delaware  General  Corporation  permits a corporation to
indemnify its  directors and officers  against  expenses,  judgments,  fines and
amounts paid in settlement actually and reasonably incurred in connection with a
pending or completed action, suit or proceeding if the officer or director acted
in good faith and in a manner the officer or director  reasonably believed to be
in the best interests of the corporation.

     Our bylaws  require us to indemnify  each person who was or is made a party
or is threatened to be made a party or is otherwise  involved in any threatened,
pending or completed  action,  suit or  proceeding,  whether formal or informal,
whether of a civil, criminal,  administrative or investigative nature, by reason
of the  fact  that  he or  she,  or a  person  of  whom  he or she is the  legal
representative,  is or was our  director or  officer,  whether the basis of such
proceeding  is an alleged  action or inaction in an official  capacity or in any
other  capacity,  from and against all costs,  charges,  liabilities  and losses
(including  without  limitation,   judgments,  fines,  ERISA  excise  taxes,  or
penalties  and amounts paid or to be paid in  settlement)  suffered and expenses
(including,  without  limitation,   attorneys'  fees  and  expenses)  reasonably
incurred by such person in connection therewith and such  indemnification  shall
continue  as to a person who has ceased to be a  director  or officer  and shall
inure to the benefit of his or her heirs,  executors and administrators.  We are
required  to  indemnify a director or officer in  connection  with a  proceeding
initiated by such person only if such  proceeding was authorized by our Board of
Directors. Our Bylaws require us to pay expenses actually incurred by a director
or  officer  in  connection   with  any  proceeding  in  advance  of  its  final
disposition;  provided, however, that if Delaware law then requires, the payment
of such  expenses  incurred  by a  director  or  officer in advance of the final
disposition  of a  proceeding  shall  be made  only  upon  delivery  to us of an
undertaking,  by or on behalf of such director or officer,  to repay all amounts
so advanced if it shall  ultimately be determined  that such director or officer
is not entitled to be indemnified under the Bylaws or otherwise. Our obligation,
if any,  to  indemnify  any person  who was or is  serving  at its  request as a
director, officer, employee or agent of another corporation,  partnership, joint
venture,  trust,  enterprise or non-profit entity shall be reduced by any amount
such  person has  collected  as  indemnification  from such  other  corporation,
partnership, joint venture, trust, enterprise or non-profit enterprise. Delaware
law also permits  indemnification  in connection with a proceeding brought by or
in the right of a company to procure a judgment in its favor.

     To the  extent  that  indemnification  for  liabilities  arising  under the
Securities Act may be permitted to directors, officers or persons controlling us

                                       10


under the provisions  described above, we have been informed that in the opinion
of the Commission,  indemnification is against public policy as expressed in the
Securities Act and is therefore unenforceable.

                                     EXPERTS

     The consolidated financial statements of TOR Minerals  International,  Inc.
appearing  in its Annual  Report (Form  10-KSB) for the year ended  December 31,
2003, have been audited by Ernst & Young,  LLP,  independent  registered  public
accounting  firm,  as set forth in their  report  thereon  included  therein and
incorporated  herein by reference.  Such consolidated  financial  statements are
incorporated  herein by  reference  in reliance  upon such  report  given on the
authority of such firm as experts in accounting and auditing.

                       WHERE YOU CAN FIND MORE INFORMATION

     We are a reporting company and file annual,  quarterly and current reports,
proxy statements and other information with the SEC. You may read and copy these
reports,  proxy  statements and other  information at the SEC's public reference
rooms, which are located at 450 Fifth Street N.W. Washington, D.C. 20549 and 500
West Madison Street, Suite 1400, Chicago, IL 60661.

     You can request copies of these  documents by writing to the SEC and paying
a fee for the  copying  cost.  Please  call the SEC at  1-800-SEC-0330  for more
information  about the operation of the public  reference rooms. Our SEC filings
are also available at the SEC's web site at "http://www.sec.  gov." In addition,
you can read and copy our SEC filings at the office of the National  Association
of Securities Dealers, Inc. at 1735 "K" Street, Washington, DC 20006.

     Also, we will provide (free of charge) any of our documents  filed with the
SEC (including exhibits), as you may reasonably request orally or in writing. To
obtain free copies, please call or write to:


                                          Elizabeth Morgan, Secretary
                                          TOR Minerals International, Inc.
                                          P.O. Box 2544 Corpus Christi, Texas
                                          78403 (316) 883-5591

                           INCORPORATION BY REFERENCE

     The SEC permits us to  "incorporate  by reference"  certain of our publicly
filed documents into this prospectus, which means that we can disclose important
information to you by referring you to other documents. Information that we file
with the SEC after the  effective  date of this  prospectus  will  automatically
update and supersede this information. We incorporate by reference the documents
listed  below and any future  filings  made with the SEC under  Sections  13(a),
13(c), 14 or 15(d) of the Securities Exchange Act of 1934, or until we terminate
the effectiveness of this registration statement.


     The following documents filed with the SEC are incorporated by reference in
this prospectus:

     1.   Our Annual Report on Form 10-KSB for the year ended December 31, 2003,
          filed on March 29, 2004.

     2.   Our  Quarterly  Report on Form 10-QSB for the quarter  ended March 31,
          2004 filed on May 17, 2004 as amended by a Form 10-QSB/A filed June 2,
          2004 and June 10, 2004 and our  Quarterly  Report on Form 10-QSB filed
          on August 16, 2004.

     2.   The  description  of our common stock  contained  in our  Registration
          Statement  on Form 8-A,  filed on November  21,  1988,  including  any
          amendments   or  reports  filed  for  the  purpose  of  updating  such
          description.

     3.   Our Current Report Form 8-K,  filed January 21, 2004,  March 11, 2004,
          July 15, 2004, July 20, 2004, August 5, 2004 and August 11, 2004.

                                       11


     This prospectus is part of a registration  statement we filed with the SEC.
You should rely only on the information incorporated by reference or provided in
this prospectus and the registration statement.

                                       12



                                     PART II
                     INFORMATION NOT REQUIRED IN PROSPECTUS


ITEM 14.  OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.

     The following  table sets forth all expenses,  other than the  underwriting
discounts and commissions, payable by TOR in connection with the registration of
the  common  stock.   All  the  amounts  shown  are  estimates  except  for  the
registration fee.

         Securities and Exchange Commission registration fee      $   2,459
                                                                  ------------
         Printing and engraving expenses                          $   2,500
                                                                  ------------
         Legal fees and expenses                                  $  12,500
                                                                  ------------
         Accounting fees and expenses                             $  10,000
                                                                  ------------
         Miscellaneous                                            $     200
                                                                  ------------
         Total                                                    $  27,659
                                                                  ------------

ITEM 15.  INDEMNIFICATION OF OFFICERS AND DIRECTORS.

     The  Registrant's   Certificate  of  Incorporation,   as  amended,  permits
indemnification   to  the  fullest   extent   permitted  by  Delaware  law.  The
Registrant's  Bylaws  require the Registrant to indemnify each person who was or
is made a party or is threatened to be made a party or is otherwise  involved in
any threatened,  pending or completed action, suit or proceeding, whether formal
or  informal,  whether of a civil,  criminal,  administrative  or  investigative
nature,  by reason of the fact that he or she,  or a person of whom he or she is
the legal  representative,  is or was a director  or officer of the  Registrant,
whether  the basis of such  proceeding  is an alleged  action or  inaction in an
official capacity or in any other capacity, from and against all costs, charges,
liabilities and losses (including without  limitation,  judgments,  fines, ERISA
excise  taxes,  or  penalties  and  amounts  paid or to be  paid in  settlement)
suffered  and  expenses  (including,  without  limitation,  attorneys'  fees and
expenses)  reasonably  incurred by such person in connection  therewith and such
indemnification shall continue as to a person who has ceased to be a director or
officer  and shall  inure to the  benefit  of his or her  heirs,  executors  and
administrators.  The  Registrant  shall be required  to  indemnify a director or
officer in  connection  with a proceeding  initiated by such person only if such
proceeding  was  authorized  by the Board of  Directors of the  Registrant.  The
Registrant's  Bylaws require the Registrant to pay expenses actually incurred by
a director or officer in connection  with any proceeding in advance of its final
disposition;  provided, however, that if Delaware law then requires, the payment
of such  expenses  incurred  by a  director  or  officer in advance of the final
disposition  of a proceeding  shall be made only upon delivery to the Registrant
of an  undertaking,  by or on behalf of such  director or officer,  to repay all
amounts so advanced if it shall  ultimately be determined  that such director or
officer is not entitled to be  indemnified  under the Bylaws or  otherwise.  The
Registrant's  obligation,  if any, to indemnify any person who was or is serving
at its request as a director, officer, employee or agent of another corporation,
partnership,  joint  venture,  trust,  enterprise or non-profit  entity shall be
reduced by any amount such person has  collected  as  indemnification  from such
other corporation,  partnership,  joint venture, trust, enterprise or non-profit
enterprise.  Delaware  law also permits  indemnification  in  connection  with a
proceeding brought by or in the right of the Registrant to procure a judgment in
its favor.

ITEM 16.  EXHIBITS.

     The  following  exhibits  either  are  filed  as part of this  registration
statement or incorporated by reference to documents  previously filed or will be
filed by amendment.  Exhibit numbers correspond to the exhibits required by Item
601 of Regulation S-K.

Exhibit No.         Description
-----------         -----------
5.1*                Opinion and consent of Jenkens & Gilchrist,  a  Professional
                    Corporation, as to legality of the common stock to be issued
                    by TOR Minerals International, Inc.
10.1*               Common Stock Purchase Agreement, effective as of January 19,
                    2005,  by and between TOR Minerals  International,  Inc. and
                    the selling stockholders (incorporated by reference from the
                    Company's Form 8-K, filed on January 21, 2004).

                                       13


10.2**+             Sales Agreement, dated March 28, 2003 and effective April 1,
                    2003,   between  TOR   Minerals   International,   Inc.  and
                    Kerr-McGee Chemical, LLC.
23.1**              Consent of Ernst & Young, LLP
23.2*               Consent of Jenkens & Gilchrist,  a Professional  Corporation
                    (included in Exhibit 5.1 herein)
24.1                Power of Attorney of certain  officers and  directors of TOR
                    Minerals International, Inc. (included on signature page)
--------------
*    Previously filed.
**   Filed herewith.
+    Confidential treatment requested.

ITEM 17.  UNDERTAKINGS.

     The undersigned registrant hereby undertakes:

     (1) To file,  during any period in which  offers or sales are being made, a
post-effective amendment to this registration statement:

          (i) To include  any  prospectus  required  by Section  10(a)(3) of the
     Securities Act of 1933;

          (ii)  To  reflect  in  the  prospectus  any  facts  or  events  which,
     individually  or in the  aggregate,  represent a fundamental  change in the
     information set forth in the registration  statement.  Notwithstanding  the
     foregoing, any increase or decrease in the volume of securities offered (if
     the total dollar value of  securities  offered  would not exceed that which
     was registered) and any deviation from the low or high end of the estimated
     maximum  offering  range may be reflected in the form of  prospectus  filed
     with the  Commission  pursuant  to Rule  424(b) if, in the  aggregate,  the
     changes  in volume  and price  represent  no more than a 20%  change in the
     maximum  aggregate   offering  price  set  forth  in  the  "Calculation  of
     Registration Fee" table in the effective registration statement; and

          (iii) To include any additional or changed material information on the
     plan of distribution.

     (2) That, for the purpose of determining any liability under the Securities
Act of 1933,  each  such  post-effective  amendment  shall be deemed to be a new
registration  statement  relating to the  securities  offered  therein,  and the
offering of such  securities at that time shall be deemed to be the initial bona
fide offering thereof.

     (3) To remove from registration by means of a post-effective  amendment any
of the securities being registered which remain unsold at the termination of the
offering.

     (4) The  undersigned  registrant  hereby  undertakes  that, for purposes of
determining  any liability  under the Securities Act of 1933, each filing of the
registrant's  annual report pursuant to Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 (and, where applicable,  each filing of an employee benefit
plan's annual report pursuant to Section 15(d) of the Securities Exchange Act of
1934) that is incorporated by reference in the  registration  statement shall be
deemed to be a new  registration  statement  relating to the securities  offered
therein, and the offering of such securities at that time shall be deemed to the
initial bona fide offering thereof.

     (5) Insofar as indemnification for liabilities arising under the Securities
Act may be  permitted to  directors,  officers  and  controlling  persons of the
registrant pursuant to the provisions referenced in Item 15 of this registration
statement or otherwise,  the  registrant has been advised that in the opinion of
the Securities and Exchange  Commission this  indemnification  is against public
policy as expressed in the Securities Act and is, therefore,  unenforceable.  In
the event that a claim for indemnification against these liabilities (other than
the  payment by the  registrant  of  expenses  incurred  or paid by a  director,
officer,  or controlling  person of the registrant in the successful  defense of
any  action,  suit  or  proceeding)  is  asserted  by a  director,  officer,  or
controlling  person in connection  with the  securities  being  registered,  the
registrant  will,  unless in the  opinion  of its  counsel  the  matter has been
settled by controlling precedent,  submit to a court of appropriate jurisdiction
the question of whether the  indemnification  by it is against  public policy as
expressed  in the  Securities  Act of 1933,  and will be  governed  by the final
adjudication of this issue.


                                       14


                                   SIGNATURES

     Pursuant to the  requirements of the Securities Act of 1933, the Registrant
certifies  that it has  reasonable  grounds to believe  that it meets all of the
requirements  for filing on Form S-3 and has duly caused Amendment No. 1 to this
Registration Statement to be signed on its behalf by the undersigned,  thereunto
duly authorized,  in the City of Corpus Christi, State of Texas, on the 16th day
of August, 2004.

                                    TOR MINERALS INTERNATIONAL, INC.
                                    By:

                                          /s/ Richard Bowers
                                          Richard Bowers
                                          President and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report
has been signed below by the following  persons on behalf of the  registrant and
in the capacities and on the date indicated.


Signatures                    Capacity with the Company         Date
----------                    -------------------------         ---------------

/s/ Richard L. Bowers         President and Chief Executive     August 16, 2004
----------------------        Officer, Director
(Richard L. Bowers)

/s/ Bernard A. Paulson*       Chairman of the Board             August 16, 2004
-----------------------
(Bernard A. Paulson)

/s/ Lawrence W. Haas          Chief Financial Officer           August 16, 2004
--------------------          and Treasurer
(Lawrence W. Haas)            (Principal Financial and
                              Accounting Officer)

/s/ W. Craig Epperson*        Director                          August 16, 2004
-----------------------
(W. Craig Epperson)

/s/ David Hartman*            Director                          August 16, 2004
-------------------
David Hartman)

                                       15



/s/ Doug Hartman*             Director                          August 16, 2004
-----------------
(Doug Hartman)

/s/ Si Boon Lim*              Director                          August 16, 2004
-----------------
(Si Boon Lim)

/s/ Thomas W. Pauken*         Director                          August 16, 2004
----------------------
(Thomas W. Pauken)

/s/ Tan Chin Yong*            Director                          August 16, 2004
-------------------
(Tan Chin Yong)

 *  By:  /s/ Lawrence W. Haas
         ---------------------------
         Lawrence W. Haas
         Agent and Attorney-in-fact

                                       16



                                  EXHIBIT INDEX

Exhibit No.         Description
-----------         -----------
5.1*                Opinion and consent of Jenkens & Gilchrist,  a  Professional
                    Corporation, as to legality of the common stock to be issued
                    by TOR Minerals International, Inc.
10.1*               Common Stock Purchase Agreement, effective as of January 19,
                    2005,  by and between TOR Minerals  International,  Inc. and
                    the selling stockholders (incorporated by reference from the
                    Company's Form 8-K, filed on January 21, 2004).
10.2**+             Sales Agreement, dated March 28, 2003 and effective April 1,
                    2003,   between  TOR   Minerals   International,   Inc.  and
                    Kerr-McGee Chemical, LLC.
23.1**              Consent of Ernst & Young, LLP
23.2*               Consent of Jenkens & Gilchrist,  a Professional  Corporation
                    (included in Exhibit 5.1 herein)
24.1                Power of Attorney of certain  officers and  directors of TOR
                    Minerals International, Inc. (included on signature page)
--------------
*    Previously filed.
**   Filed herewith.
+    Confidential treatment requested.




                                       17